MedTrace Logo

Blood Fibrocytes During an Exacerbation and Lung Function Decline in Patients With COPD in Primary Care.

NCT04005833 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2024-08-23

No results posted yet for this study

Summary

This study aims to estimate the association between blood fibrocytes measured during a suspected exacerbation and 3-year decline forced expiratory volume in one second (FEV1), in patients with Chronic obstructive pulmonary disease (COPD) in primary care, with a history of smoking, independently of the number of exacerbations and of tobacco or occupational exposure.

Conditions

Interventions

DIAGNOSTIC_TEST

spirometry

The lung function (FEV1) will be assessed at follow-up visits at 2 months, 12 months and 36 months after inclusion.

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Emmanuel Prothon, MD · University of Bordeaux

  • Patrick Berger, MD/PhD · Hospital University, Bordeaux

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-24
Primary Completion
2021-03-09
Completion
2021-06-09

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04005833 on ClinicalTrials.gov